Who owns Lumos Pharma Inc?
- Ticker: LUMO
- CUSIP Number: 55028x109
Tip: Access positions for across all investors
Analyze quarterly positions in Lumos Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Lumos Pharma stock
Who bought or sold Lumos Pharma Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Private Advisor | 745k | $2.9M | 2381% | Sep 2024 |
|
| Goldman Sachs Group | 407k | $943k | 0% | Jun 2024 |
|
| Vanguard Group | 244k | $566k | 0% | Jun 2024 |
|
| Renaissance Technologies | 214k | $828k | -1% | Sep 2024 |
|
| Leucadia National Corporation | 121k | $280k | 0% | Jun 2024 |
|
| Lion Point Capital | 91k | $211k | 0% | Jun 2024 |
|
| Greenwich Wealth Management | 76k | $295k | 0% | Sep 2024 |
|
| Wells Fargo & Company | 65k | $252k | -84% | Sep 2024 |
|
| Geode Capital Management | 55k | $214k | 9% | Sep 2024 |
|
| BlackRock | 41k | $95k | 0% | Jun 2024 |
|
| BlackRock | 40k | $154k | 100% | Sep 2024 |
|
| Bridgeway Capital Management | 28k | $64k | 0% | Jun 2024 |
|
| Dimensional Fund Advisors | 25k | $98k | -15% | Sep 2024 |
|
| Two Sigma Investments | 19k | $44k | -51% | Jun 2024 |
|
| Bank of New York Mellon | 12k | $46k | 0% | Sep 2024 |
|
| Wealth Advisors of Iowa | 12k | $45k | 0% | Sep 2024 |
|
| State Street Corporation | 11k | $26k | 0% | Jun 2024 |
|
| Key FInancial | 11k | $42k | 0% | Sep 2024 |
|
| Paladin Advisory Group | 4.4k | $17k | 0% | Sep 2024 |
|
| Tower Research Capital | 3.6k | $8.3k | 33% | Jun 2024 |
|
| Bank of America Corporation | 1.8k | $7.0k | 0% | Sep 2024 |
|
| West Financial Advisors | 784.00 | $3.0k | 0% | Sep 2024 |
|
| Advisor Group Holdings | 290.00 | $1.1k | 88% | Sep 2024 |
|
| Morgan Stanley | 277.00 | $643.000100 | 67% | Jun 2024 |
|
| Royal Bank of Canada | 50.00 | $0 | -36% | Sep 2024 |
|
| Jpmorgan Chase & Co | 13.00 | $50.000600 | 0% | Sep 2024 |
|
| Live Oak Investment Partners | 11.00 | $43.000100 | 0% | Sep 2024 |
|
| Jones Financial Companies, L.L | 4.00 | $16.000000 | 100% | Sep 2024 |
|
| Qube Research & Technologies | 3.00 | $7.500000 | 0% | Jun 2024 |
|
Who sold out of Lumos Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Acuitas Investments | Jun 2024 | 141k | $328k |
| Millennium Management | Jun 2024 | 37k | $86k |
| Two Sigma Advisers | Mar 2024 | 32k | $90k |
| Marquette Asset Management | Jun 2024 | 26k | $60k |
| Envestnet Asset Management | Jun 2024 | 20k | $45k |
| Citadel Advisors | Jun 2024 | 19k | $44k |
| Atria Investments | Jun 2024 | 11k | $25k |
| Redwood Wealth Management Group | Jun 2024 | 500.00 | $1.2k |
| International Assets Investment Management | Jun 2024 | 38.00 | $88.000400 |